AzTrials
AzTrials

GamblingCONGANCT04714008

Covid-19 and ONline GAmbling

An observational study of Gambling and Covid19, run by Nantes University Hospital at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The coronavirus disease 2019 (COVID-19) pandemic represents a major threat to global health. Since the beginning of the COVID-19 epidemic, all eyes have been focused on the significant somatic complications of COVID-19, but the impact on behaviors, particularly those that can lead to addictive disorders, remains… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Gambling, Covid19
How many people
120,000 participants
Where
1 siteFrance
Study dates
1 Dec 2020to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Gamblers registered on the authorized gambling websites of France and Sweden, whatever the type of gambling activity.

Who may be able to join

  • Gamblers registered on the authorized gambling websites of France and Sweden, whatever the type of gambling activity. Those gamblers will be drawn at random from the entire active accounts datasets from the participating operators/regulatory authorities.

Who cannot join

  • No exclusion criteria will be applied

Trial locations and contacts

1 site in 1 country.

France1 site
  • Nantes University Hospital

    Nantes, 44093

Other trials in France

About this study

Official title: Impact of the COVID-19 Pandemic on Online Gambling in France and Sweden

The coronavirus disease 2019 (COVID-19) pandemic represents a major threat to global health. Since the beginning of the COVID-19 epidemic, all eyes have been focused on the significant somatic complications of COVID-19, but the impact on behaviors, particularly those that can lead to addictive disorders, remains little studied. A set of factors could explain a change in gambling activities, both in number of gamblers and in intensity of practices, due to the pandemic. On the one hand, the reduction or even the interruption of sporting and horse racing competitions may induce a decrease in these activities (both online and offline). Moreover, the closure of certain gambling venues and travel restrictions may also lead to a decrease of offline gambling activities in general. On the other hand, gamblers who can no longer perform their usual gambling activity could refer to available online gambling activities (poker, lotteries, casinos, etc.). Moreover, the threat of a financial crisis, the negative impact on psychological well-being (due to social isolation, stress of being infected, etc.), and increased time spent freely online, could also very largely motivate an initiation or an exacerbation of the gambling activity, especially online and in people in a situation of vulnerability. Both in France and Sweden, the closing of sports and horse race events has led to a sharp decrease in sports and horse-race betting. In both countries, the increase in other gambling types, including illegal gambling, and their potential for gambling problems is a source of concerns for public health authorities. As a consequence, more research is promptly needed in this area.

The use of gambling tracking data, widely acclaimed in recent years in research on online gambling given its ecological nature, could allow observing longitudinally changes in online gambling practices (both the raw gambling activity and risky behaviors) and in the use of responsible gambling (RG) tools due to the pandemic. Moreover, the combination of French and Swedish data will allow comparing two countries with very distinct politics regarding the pandemics, i.e. a lockdown in France in March - May 2020 and then in November - December 2020 compared to no lockdown in Sweden. Finally, gambling in women is on the rise and women display specific gambling behaviors, especially in early stages of the online gambling practice. The project will include the investigation of gender specificities both in the investigation of the impacts of the pandemic and in the comparison of French and Sweden gambling behaviors. Age, type of gambling activity and country (France / Sweden) will also be taken into account.

Conditions
Gambling, Covid19
Keywords
Gambling, Internet, Gambling tracking data, France, Sweden, Covid 19
Medical subject headings
Gambling, COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04714008
Study groupRoleWhat they receive
Active gamblers in 2019/2020Three panels of 40 000 gamblers active in 2019 and 2020, either in France or Sweden
Newly registered gamblers in 2019 or 2020 (France and Sweden)Six panels of 10 000 gamblers who newly registered either during the period of March-May 2019 or of March-May 2020, either in France or Sweden

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Trajectories of gambling behaviors across time before and during the pandemics

    Because "gambling activity" is not directly measured as such, but rather observed as a combination of gambling indicators (e.g. money spent, type of game, numbers of gambling days, etc.), these indicators will be included as observed variables, explained by a latent (unobserved) variable, namely "gambling activity". Subgroups of gamblers with distinct impacts of the COVID-19 on their gambling activities will be identified.

    Measured: 2019-2020

Secondary outcomes (3)
  1. Typologies of gamblers based on their gambling activity and their use of RG tools outside the pandemics

    Profiles of gamblers who have similar gambling behaviors and/or use of RG tools

    Measured: 2019

  2. Gambling activity of early registered gamblers, during and outside the pandemics

    Typologies of gambling behavior trajectories across the 6 months after registration

    Measured: 6 months after registration

  3. Typologies of gamblers based on their gambling activity and their use of RG tools according to the type of gambling activity, gender, age groups and country

    Profiles of gamblers who have similar gambling behaviors and/or use of RG tools, compared according to the type of gambling activity, gender, age groups and country

    Measured: 2019-2020

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jan 2021
  2. Study start1 Dec 2020
  3. Primary completion31 Dec 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Retrospective
Enrolment
120,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04714008
Sponsor's protocol ID
RC21_0010
Acronym
CONGA
Status last verified
Sep 2025
First submitted
14 Jan 2021
Last updated
1 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Balem M, Karlsson A, Widinghoff C, Perrot B, Challet-Bouju G, Hakansson A. Gambling and COVID-19: Swedish national gambling data from a state-owned gambling sports and casino operator. J Behav Addict. 2023 Mar 30;12(1):230-241. doi: 10.1556/2006.2022.00089. Print 2023 Mar 30.

    PubMed 36995980

Questions about this trial

What is this clinical trial studying?

An observational study of Gambling and Covid19, run by Nantes University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Trajectories of gambling behaviors across time before and during the pandemics (time frame: 2019-2020). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04714008, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in